Perinatal Mortality and Morbidity in Diabetes Mellitus Complicating Pregnancy by Sampathkumari, S
       
 
PERINATAL MORTALITY AND MORBIDITY IN 
DIABETES MELLITUS COMPLICATING 
PREGNANCY 
 
 
 
 
 
Dissertation submitted for 
M.D., Branch II 
OBSTETRICS AND GYNAECOLOGY 
 
 
 
 
 
 
 
 
 
 
 
THE TAMILNADU DR. M.G.R MEDICAL UNIVERSITY 
CHENNAI 
 
FEBRUARY 2006 
       
 
 
 
 
BONAFIDE CERTIFICATE 
 
 
This is to certify that this dissertation titled ‘Perinatal Mortality and 
Morbidity in Diabetes Mellitus Complicating Pregnancy’ has been done 
by Dr. S. Sampathkumari is her original work and this manuscript is an 
outcome based on the results of the study conducted by her at this institution. 
This dissertation is submitted in partial fulfillment of The Tamilnadu 
Dr.MGR Medical University, Chennai regulations for the award of the degree 
M.D., (Obstetrics & Gynaecology). 
 
 
 
 
     Dr. V. Madhini M.D., D.G.O., M.N.A.M.S., 
     Director & Superintendent 
Institute of Obstetrics & Gynaecology & 
Govt. Hospital for Women and Children 
Madras Medical College 
Chennai. 
 
 
 
 
 
 
       
 
 
ACKNOWLEDGEMENT 
 
 
I sincerely wish to thank and record my deep sense of gratitude to the following persons 
for their valuable help and timely advices, without whose encouragement and guidance this 
study would not have progressed and reached the shape it is today. 
 
Dr.Kalavathy Ponniraivan B.Sc.,M.D., Dean, Madras Medical College, Chennai 
Dr. Shakundala Barathi M.D, D.G.O., (Retd) Director of IOG 
Dr. V.  Madhini M.D., D.G.O., M.N.A.M.S., Director & Supdt. of IOG, Chennai 
Dr. R.S. Hariharan M.D., Professor of Diabetology, Govt. GH & Madras Medical 
College, Chennai 
Dr.Arasan Seeralan M.D., Neonatalogist, I.O.G, Chennai and 
Dr.Padmavathy Palanisamy M.D, D.G.O, Gynaecologist, I.O.G, Chennai 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
CONTENTS 
 
 
 
 
 
 
Introduction         1 
Review of Literature       2 
Aims of the Study        15 
Materials and methods       16 
Results and Observation       18 
Discussion         27 
Summary         35 
Conclusion         37 
Appendix 
 Proforma         
 Bibliography      
Master Chart 
 
 
 
 
 
 
 
 
       
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
       
Introduction 
 
“ In every child who is born under no matter what circumstances and of no matter what 
parents, the potentiality of human race is born again, and in him too, once more and each 
of us our terrific responsibility towards human life”                                    James Agee  
 
Gestational Diabetes mellitus and other categories of glucose intolerance during pregnancy 
are one of the causes for increased perinatal mortality. But nowadays with pre conceptional 
counselling, early screening and advances in management of diabetic pregnancy have 
reflected in the continuous reduction mortality and morbidity in the infants of diabetic 
mothers.  
 
Hypoglycemia, hyperbilirubinemia are managed with little difficulty. Respiratory Distress 
Syndrome and Macrosomia are now largely preventable with good glycemic control. The 
unresolved problem at present is the prevention of malformation in diabetic pregnancy. 
 
With the above in mind the perinatal outcome at Institute of Obstetrics and Gynaecology, 
attached to Madras Medical College, Chennai was analysed for possible clues in effective 
management of diabetic mothers who turn up at the institute.  
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REVIEW OF 
LITERATURE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
Review of Literature 
History 
 The history of Diabetes Mellitus is as old as human kind. However, en Egyptian papyrus 
inscription of 1500 B.C has the first record of Polyuria related to diabetes. The disease was 
prevalent in the days of Hippocrates (466 – 372 B.C) and was considered rare and 
incurable. The symptom was noted as ‘ to make water much or often’ a condition known to 
be ‘wasting of the body’. 
 
The naming of the disease as Diabetes is credited to Aretaeus of Cappadocia (AD 30 – 90). 
The term diabetes means to pass through or to siphon. The severity of the illness and the 
frustration and hopelessness it caused was not only to the patient but also to the physicians 
as well. Celsus (30 BC – AD50) described the individuals with diabetes as patients with 
discharge of urine greater than the amount of fluid taken in by mouth. 
 
Avicenna (AD 980 – 1027) has observed in his writing about Arabian medicine that 
diabetic patients have irregular diet associated with thirst, mental exhaustion, inability to 
work and loss of sexual function. He was alarmed by these factors and believed that 
diabetes affected the liver and caused its enlargement. The Hindu writings of the sixth 
century refer to the ailment as honey urine. 
  
Although observations on diabetes were seen in almost all parts of the world attempts on 
possible causes were witnessed only in the recent centuries. Sylvanus (1478 – 1555) 
opined that diabetes was a disease of blood and Willis Wyatt (1621 – 1675) explained that 
the sugar present in the urine of diabetics represented excretion of sugar that was initially 
in the blood. In 1682, Brunner created history bay making an animal model and his 
experiment was corroborated in Cawley’s (1688) diagnosis that the disease resulted from 
the injury to pancreas. 
  
18th century experiments paved the way for systematic treatment and therapeutic approach 
to deal with diabetes. Physicians by now were convinced that the disease was caused by 
the inability of the body to handle carbohydrates properly. It was Rolls in 1797, who had 
attempted to control the disease by dietary management. Bouchardat (1806 – 1866) 
advocated for dietary management and exercise by the use of green vegetables, fresh fats 
       
substituting carbohydrates, avoidance of milk and alcohol. Naunyn too suggested dietary 
management, as he believed that when the patient is sugar free his tolerance level 
increases. Therefore the Alpha and Omega care of diabetes is dietary treatment and not 
drugs was his ultimate conclusion. Sheffer in 1895 suggested that the islets of Langerhans 
when diseased produced daibetes. Opie of U.S further amplified this in 1901. The 
degeneration of the islets of Langerhans in the pancreas altered the form and the function 
of the internal secretion that caused diabetes was his theory. Minkowski and von Mering 
experimented a dog by conducting pancreatectomy. Thus the work of Minkowski and the 
observation of Opie began to close the link between the islet cell disease and diabetes. 
 
Discovery of Insulin 
Paulesco, a Physiologist from Bucharest in1916 extracted pancreine from pancreas which 
when injected gave a temporary relief to the pancreatectomised dog. Zuelzer et al (1908) 
prepared a improvised version prepared an extract from the expressed juice of the 
pancreas. This was tested on pancreatectomized dogs with hyperglycemia and ketonuria, 
eight diabetic humans and four other humans with ketosis. This experiment came close to 
the discovery of insulin by Banting and Best in 1921.As we all know good science is 
created in the morning. Banting apparently awoke at 2.00 a.m. came up with the idea of 
preparing insulin. 
 
Diabetes in Pregnancy 
Until 1856 there was no report of DM complicating pregnancy. Blott had written that ‘true 
diabetes in inconsistent with conception’. In 1892, a report published by Duncan, described 
22 pregnancies with diabetes. In 1909 Reel collected 66 cases, 27 % died at the time of 
labour or within 1 – 2 weeks afterwards, another 22 % died within 2 years, one-eighth of 
pregnancies ended in abortion and one-third that went to term the baby was born dead. 
Beunewitz quoted a series of 19 cases, 10 of which died during labour or shortly thereafter. 
This trend continued until the discovery of insulin. 
  
Diabetes was considered as a disease with dismal prognosis and reproductive success was 
not common and pregnancy worsened the disease. In 1920 De Lee wrote that sterility was 
common among diabetes probably due to the atrophy of the uterus and ovaries, causing 
premature menopause, abortion and premature labour in 33 % of pregnancies. The foetus 
       
died when pregnancies went to term with an overall perinatal mortality of 60 – 70 %. 30 % 
of the mothers died due to ketoacidosis. 
 
The advent of Insulin 
Insulin drastically reduced the maternal mortality from 45 % to just over 2 % shortly but 
the perinatal mortality did not come down rapidly. Very large babies and associated 
traumatic injury to the foetuses and the mothers during parturition was noy helped by 
insulin. The problem of neonatal hypoglycemia, congenital malformations, toxemia of 
pregnancy and the like continued to haunt affecting the outcome. 
 
It was also observed that beyond 36 weeks of gestation the risk of still birth rose 
significantly – an alarming ten fold increase, and foetal mortality was about 25 %, if the 
birth weight was 3.2 kg or 70 % if the weight was 4.5 kg. Due to this diabetic mothers 
were delivered routinely on or before 36 weeks by section or by induction if foetal death 
had not already occurred or when maternal complications necessitated.  
 
Following years saw the emergence of newer protocols aimed at improving the foetal 
outcome. White claimed in 1945 a 97 % foetal survival with normal hormonal balance and 
a 47 % survival in abnormal hormone balance. Pedersen of Copenhagen in 1954 showed 
that the foetal mortality rate was lower when being followed over a long period than in 
those who were seen first at or about the time of delivery. Advances like new types of 
insulin (long acting type and human insulin) and tools like estriol measurement, USG, 
antepartum foetal heart rate testing, foetal blood sampling techniques, glucose meters, 
insulin pumps, neonatal intensive care units are being used to improve the foetal outcome. 
Karlsson & Kjellmer’s retrospective study established a relationship between glycemic 
control and perinatal mortality. This led to a new trend in diabetics care. Stringent 
maintenance of ambient glucose level resulted in average perinatal mortality rate less than 
5 %. The cause of maternal deaths has shifted from diabetic ketoacidosis to cardiac renal 
complications. The impressive strides achieved in diabetic care these days have enabled 
expectant mothers to enjoy pregnancy performance and foetal outcome similar to that of 
non-diabetic patients. Yet problems like macrosomia and congenital malformations still 
remain unresolved. The incidence of birth defects is reported to be 6 – 12 %. Clinical and 
laboratory studies suggest that these malformations are caused by the derangement in 
metabolism during organogenesis. 
       
  
Gestational Diabetes Mellitus 
GDM defined as ‘ Carbohydrate intolerance of varied severity with the onset or first 
recognition during the present pregnancy’. It is estimated to occur in 2 – 5 % of 
pregnancies. 
 
Classification 
 
Classification of Diabetic mothers 
Revised Whites’ Classification  (1980) 
I Gestational Diabetes 
  Abnormal GTT, but euglycemia maintained by diet alone 
  If diet alone is insufficient, insulin is required 
II Pregestational Diabetes 
 
NDDG Classification (1979) 
 Type I IDDM  Insulin dependent DM 
 Type II NIDM  Non Insulin dependent DM 
 Type III GCI  Gestational Carbohydrate Intolerance 
     Non Obese     & Obese 
 
Fuel Metabolism in normal pregnancy 
Pregnancy is characterized by maternal adaptations such as facilitated insulin action during 
the first half of pregnancy and diabetogenic stress during the second half of the pregnancy. 
The metabolic changes of pregnancy in the fed state are dominated by a single 
characteristic; resistance to glucose lowering effects of insulin. These changes appear to be 
related to the effect of hormones including human placental lactogen, HPL, pregesterone, 
prolactin and cortisol. The progressive insulin resistance of pregnancy results in large part 
from metabolic actions of hormones. As a result, one of the main forces exerted by the 
conceptus on maternal metabolism causes the blunting of insulin’s action on glucose 
uptake in insulin target tissues (i.e., skeletal muscle and adipose tissue). The reduction in 
insulin-mediated glucose uptake that occurs in pregnancy results from inefficient coupling 
between activation of insulin cell surface receptors and translocation of GluT4 molecules 
to the cell surface. 
       
The metabolic changes in fasting state in pregnancy are similar to that occurring during 
fasting in non-pregnancy but in a rapid and greater degree. Thus Freinkel has referred to 
the metabolic profile of fasted women as ‘accelerated starvation’. The two major 
components of accelerated starvation are (1) reduction in circulating glucose concentration 
and (2) accelerated lipolysis and ketogenesis. 
 
In short, facilitated anabolism in the fed state and accelerated starvation in the fasted state 
characterise the maternal fuel adaptations during pregnancy. These hormonal and 
metabolic changes are geared towards facilitated anabolism under the actions of insulin 
throughout pregnancy. However in the second half of the pregnancy, insulin resistance and 
diabetogenic stress necessitate compensatory increased insulin secretion. Hence the clinical 
expression of gestational diabetes, where this compensation is inadequate, usually occurs 
during the second half of pregnancy Fuel Metabolism in Diabetic Pregnancy 
 
The effect of diabetic pregnancy on fuel metabolism is one of under utilisation of 
exogenous fuel in the fed state and over production from endogenous sources in the fasted 
state. 
     Fasted State  Fed State 
 
      Normal pregnant state Accelerated  Facilitated  
      starvation  anabolism 
 
     Diabetic Pregnant state Hyper accelerated Reduced facilitated 
      Starvation  anabolism 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
Diabetes begets diabetes 
Reece suggests the chain of events in that many of the offsprings of diabetic mothers will 
be predisposed to GDM in second generation. This suggests that DM can predispose to 
more DM thus contributing to the overall increasing burden of DM in the population. 
 
    Increased Maternal  
     Fuels 
 
 GDM 
 
        Altered Foetal 
 Impaired Adult     islet function 
 Islet function 
 
        Child Obesity 
 
 
    Pubertal impaired 
    Glucose intolerance 
 
However this process is potentially preventable by research works more effectively done to 
find a solution for early diagnosis and prevention of GDM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
Screening 
Screening for GDM is performed with 50 gm oral glucose load between 24 and 28 weeks 
followed by 1 hr. venous plasma glucose level. Screening test is performed when 
diabetologic effect of pregnancy is peaking30. If the test reveals a result ≥ 140 mg/d, patient 
is scheduled for 3 hr 100gm – OGTT. 
 
       Patient with risk    Uncomplicated patient 
      Factors at 20 wks    24 –28 wks * 
 
    
 
    50 gm glucose 
          No  challenge ≥ 140 mg/dl  Yes 
 
 
 
    Re-screen by 32-34 wks    Positive 100gm 
    if risk factors present     OGTT 
 
 
      Re-test OGTT by         No   Yes 
      32 –34 wks if risk 
      factors present             GDM 
       FPG ≥ 105 mg/dl 
 
      No  Yes 
      Diet 
     SBGM        
 
        Insulin 
 FPG ≥ 105 mg/dl**       
2-hour ≥ 120 mg/dl 
 
 
    No  Yes 
             
SBGM = Self blood glucose monitoring 
FPG = Fasting plasma glucose 
 
* Screening is not required if the patient meets all of the following criteria:  
1) Less than 25 years of age 
2) Normal body weight 
3) No first degree relatives with DM 
4) Not of Hispanic, Native American, Asian, African – American ethnic groups 
** Initiation of insulin therapy at FPG of 95 mg /dl has been advocated by some investigators 
 
 
       
Diagnosis 
Early detection and appropriate treatment of GDM provides the opportunity to prevent 
adverse outcomes for a mother and their children. 
Diagnostic criteria for GDM using 100 gm OGTT 
          O’Sullivan 21* NDDG 48** Carpenters & 
         Coustan 49* 
  Fasting  90 mg/dl  105  95 
1 hour   165 mg /dl  190  180 
2 hour   145 mg /dl  165  155 
3 hour   125 mg /dl  145  140 
* Venous whole blood, Somogyi – Nelson analysis ** Plasma glucose oxidase 
The diagnosis requires any two values to meet or exceed those listed above. 
ACOG and the expert committee on the diagnosis classification of DM recommend NDDG 
criteria for the diagnosis of GDM. ACOG recommended GDM screening based on risk 
factors32. Others said that half of all patients GDM have no identifiable risk factors. Latest 
ACOG Technical Bulletin on Diabetes and Pregnancy suggest selective screening in low 
risk clinical setting such as teen clinics and universal screening in other settings31. 
 
Risk factors requiring Diabetic screening 
1) Obesity (>15 % of non pregnant ideal body weight or BMI > 29 %) 
2) Positive family h/o diabetics 
3) History of still birth 
4) History of delivery of large infant 
5) Glycosuria 
6) History of unexplained neonatal death 
7) History of congenital anomaly 
8) History of prematurity 
9) H/o pre eclampsia as a multipara 
10) Poly hydramnios 
11) H/o traumatic delivery with associated neurogenic disorder of infant 
12) Poor reproductive history 
13) Chronic Hypertension 
14) Recurrent UTI or severe moniliasis 
15) Age > 30 years 
16) H/o Diabetics in previous pregnancy 
       
Maternal Morbidity 
Many studies have documented an increase in pre eclampsia, Polyhydramnios and 
operative delivery in pregnancies complicated by GDM33,34,35. The Toronto Tri-Hospital 
Gestational project, a prospective cohort study evaluating maternal and foetal outcomes 
with increasing carbohydrate intolerance, observed significant association between glucose 
intolerance and increased incidence of caesarian delivery, pre eclampsia and length of 
maternal hospitalisation. 
 
Women with GDM also have significant risk of developing diabetes later in life. Coustan 
and associates studied former GDM women and found diabetes or impaired glucose 
tolerance (GTT) in 6 % of the those tested 0 – 2 years, 13 % at 3 – 4 yrs, 15 % at 5 - 6 yrs 
and 30 % at 7 – 10 yrs post partum. Other studies have documented type 2 diabetes 3 – 5 
years post partum in 30 – 50 % of women who had a pregnancy complicated by DM.36, 37 
 
Peter and associates found that episodes of insulin resistance due to additional pregnancies 
increased the rate of developing type 2 diabetes independent of pregnancy – associated 
weight gain. They also found the relative risk for type 2 diabetes was 1.95 for every 10 
pounds gained during follow-up adjusting for the number of pregnancies and other risk 
factors.38 
 
Perinatal Mortality and Morbidity 
Infants of mother with GDM (IGDM) are not at increased risk for congenital anomalies 
unless these women have pre-existing DM. However, IGDM do have an increased risk of 
perinatal mortality and morbidity including hyper bilirubinemia, macrosomia and birth 
trauma, hypocalcemia and hypoglycemia. 
 
O’Sullivan observed a fourfold increase in perinatal mortality rates in pregnancies 
complicated by improperly managed GDM.39 Several other studies have found an 
increased rate of still birth in untreated GDM.40 Today in pregnancies identified and treated 
appropriately, intra uterine foetal demise is not increased in GDM. 
 
Silverman studied the children of women with both pre GDM and GDM and found IGT in 
adolescent children were 13 times more frequency than control adolescents.41 Silverman 
documented that by 8 years of age 50 % of children of diabetic mothers had weights above 
       
the 90th percentile compared to children of women without diabetes42. Plagemann and 
associates confirmed that children of mothers with pre gestation and GDM have high 
incidence of obesity43. Pethitt and associates studied the children of Pima Indians form 5 – 
19 yrs of age and found a significantly higher body weight as compared to control 
subjects.44 
 
Diabetes and Foetal Growth 
Maternal diabetes is characterised by increased plasma concentrations of glucose, free fatty 
acids, triglycerides and some amino acids. Pederson first proposed an explanation of the 
pathophysiology of the infant of diabetic mother, which has become known as the 
hyperglycemia hyperinsulinemia hypothesis. 
 Mother  Foetus   Neonate  Child 
 ↓ Insulin  P Macrosomia  Hypoglycemia  Obesity 
 Sensitivity        L 
    A 
↑ Plasma          C 
   - Glucose  E 
-Aminoacid  N ↑ insulin     IGT 
- Lipids   T 
A                           
 L       ↑ Mixed Nutrients         Diabetes 
 
Although embryonic cell proliferation is occurring at a very rapid rate and embryonic 
height is increasing rapidly during the period of embryogenesis, 95 % of eventual weight 
of human foetus is gained during the second half of the pregnancy. The disparity between 
the foetal and placental weight gain at 20 weeks of gestation can be viewed as suggestive 
evidence that factors other than the placental transport function are involved in controlling 
foetal growth. 
 
Management 
Dietary Therapy is the foundation for the treatment of GDM. ADA has recommended 
dietary therapy to start with 2000 – 2500 kcal /dl with 50 – 60 % carbohydrate (complex, 
high fibre) 10 – 20 % proteins and 25 – 30 % fats (< 10 % saturated). New ADA specify a 
protein level of 10 – 20 % calories but now allow greater flexibility in the levels of 
carbohydrate and fats.45 
 
       
Jovanovic – Peterson associated found that former dietary recommendations lead to 
significant weight gain and postprandial hyperglycemia requiring insulin therapy in 50 % 
of patients.46, 47 They suggested a diet with less calorie intake calculated by 30 kcal/kg for 
the normal sized individual’s current pregnancy, 24 kcal/ kg for overweight patients and 12 
kcal/ kg for morbidly obese women. Carbohydrate composition was < 45 % at breakfast, < 
55 % at lunch and 50 % at dinner. Occasionally carbohydrate composition was decreased 
to 33, 45 and 40 % respectively for further improvement of glycemic control. 
 
Restricting caloric intake by 50 % (1200 kcal/ dl) improves glycemic control but produces 
ketonemia and ketonuria.48 Moderate (33 %) caloric restriction reduces macrosomia rates 
without adversely affecting neonatal outcomes or causing ketonemia. 
 
Gunderson reviewed intensive nutritional therapy, emphasising a limit on total 
carbohydrate and distribution of carbohydrate throughout the day at several meals and 
snacks in order to achieve normal blood glucose levels and prevent starvation ketosis. 
 
Insulin 
ACOG criteria for initiating insulin therapy included testing plasma glucose level ≥ 105 
mg/ dl and 2 hour plasma postprandial levels ≥ 120 mg/ dl. Lower rate of macrosomia 
when fasting is > 95 mg.49 However, prophylactic insulin treatment is not advised in-
patients where fasting and postprandial values remain within the recommended range. 
 
Insulin Dosing 
 Type  A.M     P.M 
 NPH  4/9 of total insulin  1/6 of total insulin at bedtime 
 Regular 2/9 of total insulin  1/6 of total insulin at dinner 
 Total  2/3    1/3 
 Total daily insulin is calculated by  0.7 U/ kg –  6  –  8 weeks 
              0.8 U/ kg – 18 – 26 weeks 
              0.9 U/ kg – 26 – 36 weeks 
               1.0 U/ kg – 36 – 40 weeks 
 Adopted from Jovanovic – Peterson  
 Review of GDM and low calorie diet, Diabetes Mel. Rev., 12: 287 – 308, 1996. 
 
       
There are no specific studies declaring one type of insulin or certain regimen as superior 
affecting any perinatal outcome. Physician should expect to increase the insulin dosage as 
pregnancy program and insulin resistance increases. No published guidelines are available 
to help family physicians treat patients with GDM who require insulin. When necessary, 
collaborative care by obstetricians or perinatologists is advisable.  
 
Lispro insulin is rapid onset, earlier peak and shorter duration of effect than regular insulin. 
This pattern of action is similar to healthy pancreatic insulin release in response to a 
meal.50 Lispro is considered a pregnancy category B drug.51 Recently a letter in New 
England Journal of Medicine described two cases of long anomalies in patients taking 
Lispro.52 
 
Exercise has been suggested as an adjuvant therapy in GDM since glycemic control has 
been shown to improve with exercise regimens. 
 
Oral Hypoglycemic Medications 
Oral drug has not been recommended because of potential teratogenicity and transport of 
glucose across the placenta (causing prolonged neonatal hypoglycemia).53 Although first 
generation hypoglycemic agents (chlorpropamide [Diatend] tolbutamide) shown to cross 
placenta, recent in vitro and vivo existence has determined the glyburide (micronase) does 
not enter foetal circulation.54,55 
 
RCT → Glyburide therapy resulted in comparable maternal outcome (glycemic control, 
caesarian delivery) and neonatal outcome (macrosomia, hyperglycemia, ICU admission). 
ACOG56 and the ADA57 agree that glyburide should not be practiced for the treatment of 
GDM until additional RCTS support its safety and effectiveness. 
 
Delivery Timing 
Patients with uncomplicated, diet controlled GDM are allowed to progress to term unless 
other complications arise. Amniocentesis to document foetal pulmonary maturity if 
delivery before 39 weeks indicated. 
 
Foetal surveillance should begin at 40 weeks gestation with twice weekly NST in 
pregnancy complicated by diet controlled GDM. Antenatal testing initiated earlier at 32 
       
weeks gestation in GDM requiring insulin or pregnancy or in pregnancy complicated by 
hypertension or prior stillbirth. Foetal movement counting should be performed by all 
patients after 28 weeks gestation.  
 
During labour and delivery, maternal plasma glucose levels are monitored at the bedside 
every 1 – 2 hours. Plasma glucose levels should be kept < 90 mg/ dl in order to decrease 
the risk or severity of neonatal hypoglycemia.28 
 
Postpartum 
GDM are at high risk for developing type 2 diabetes in future, they should be tested for 
diabetes six weeks after delivery via testing blood glucose measurement on two occasions 
or two hour oral 75 g glucose tolerance test. 
  Normal  < 140 mg/ dl 
  140 – 200 mg  IGT 
  > 200 mg  Diagnostic of Diabetes. 
  
Screening for diabetes repeated annually especially for those who had elevated fasting 
blood sugar during pregnancy.29 
  
Breast-feeding improves glycemic control and should be encouraged in women who had 
GDM.58 
 
Contraception should be discussed, because women who have diabetes during one 
pregnancy are likely to have the same condition in a subsequent pregnancy. There are no 
limits on the use of hormonal contraception in patients with a history of GDM. 
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Aims and Objectives 
 
 
1. To know the incidence of DM complicating pregnancy in Women & Children 
Hospital, Institute of Obstetrics and Gynaecology, attached to Madras Medical 
College, Chennai. 
 
2. To know the Perinatal Mortality and Morbidity in DM complicating pregnancy. 
 
3. To know the maternal outcome in DM complicating pregnancy. 
 
4. To compare the mortality with GDM and known Diabetes preceding pregnancy 
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Materials and Methods 
Materials and Methods 
This present prospective study has been conducted at the Institute of Obstetrics and 
Gynaecology, Women and Children Hospital, Egmore, attached to Madras Medical 
College, Chennai during August 2004 to July 2005. 
 
All cases delivered in labour ward were taken in to consideration. Both Gestational 
Diabetes and Diabetes preceding pregnancy were included. Patients in all age groups, 
parity and presentation with confirmed increased sugar value were included along with 
associated maternal complication cases. 
 
Methods: 
All patients with h/o Diabetes complicating pregnancy were assessed with:- 
I. Thorough history regarding 
1. Routine – for age and socio economic status 
2. Obstetric history – parity, previous Obstetric history 
3. Positive family h/o Diabetes 
4. H/o still birth, weight of previous babies 
5. H/o any congenital anomaly or unexplained death 
6. When was the disease detected – period of detection 
7. H/o diabetes in previous pregnancy and  
8. Type of treatment taken/ given 
II. Clinical Examination regarding 
1. Nutritional status / Anemia/ Obesity 
2. Vital signs 
3. Abdominal Examination regarding GA, Hydramnios, Contraction, weight 
of babies, foetal presentation and foetal well being 
4. Vaginal examination wherever needed to assess the mode of delivery. 
III. Laboratory Investigation 
Ultra Sonogram 
Hb, PCV 
Fasting blood sugar on the day of delivery 
Monitoring fasting and post prandial sugar level 
Glycemic profile 
       
Post op/ Postnatal blood sugar 
Routine blood sugar, bilirubin, calcium, electrolytes for all babies 
X-ray chest, ECG & Echo for all babies 
 
All patients were admitted for observation and delivery – term and nearing term. Mode of 
delivery either by vaginal or abdominal route was decided upon information such as 
history, size of baby, associated factors, glycemic control, foetal condition in uterus and 
maternal complication apart from the age and weight of the babies. 
 
Patients selected for vaginal delivery were watched vigilantly in all the 3 stages of labour, 
carefully monitored to detect the foetal distress at the earliest. In cases where the 
abdominal route was decided some were elective / emergency depending on previous 
history, associated factors, infatibility status, bad obstetric history with weight of baby, 
glycemic control, fasting blood sugar were analysed. 
 
Corticosteroids were administered for pre term and Diabetologists’ opinions were sought 
and obtained regularly. The relationship between perinatal outcome and complication in 
labour was documented and babies were admitted in neonatal units for care and further 
investigation. 
 
Foetal variables that influence the morbidity and mortality were asphyxia, malformations, 
RDS, Sepsis, Hypoglycemia, Hyperbilirubinaemia, Hypercalcimia, Macrosomia, 
Polycythemia and Cardiac Evaluation. 
   
Postnatal blood sugar for mother was ascertained and insulin was stopped almost in 90% of 
cases and the cases were followed up in Diabetogy OP and Postnatal OP after 6 weeks. 
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Results and Observation 
Incidence 
 
 Total no. of Deliveries:       17,450 
 No. of deliveries complicated by Diabetes: 153 
 Incidence in IOG: 0.87 % 
  
Deliveries complicated by Diabetes: 
 
 Gestational Diabetes:   120 78.4% 
 Diabetes Mellitus complicating   33 21.56%  
 
Age & DM  
    
< 30 years > 30 years Statistical  
   Nos. % Nos. % Significance  
 
 DM  14 44.6 19 55.4 Chi Square Value 
 n = 33          5.89 
 
GDM  81 67.5 39 32.5 ‘P’ Value 
n = 120          0.0152278  
 
Incidence of known diabetics is higher in the higher age group of more than 30 yrs.  i.e., 19 
out of 33. In the case of GDMs, patients less than 30 years are more than double of patients 
who are more than 30 years as evidenced in the ‘P’ and Chi square values. 
 
Parity in Diabetes 
   
  No. of deliveries  153 (DMCP)   17450  (All)       % 
  Primi    41      9630     0.43 
  G2  & G3    95      7743     1.23 
  > G4    17                     77     22.08  
When this incidence of parity in DM complicating pregnancies is compared with the total 
deliveries, gravida 2 & 3 account for about 62 % in DMCP and is about 18 % more than 
the percentage in all deliveries. Again G4 and more in DMCP is 7 % more than that of all  
 
       
 
Incidence with BMI 
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deliveries. In so far as the primis are concerned the DMCP incidence is less than half of all 
deliveries. 
 
 
    Primi    > 1 para   Statistical 
    Nos. %   Nos.    %   Significance 
 
No. of deliveries 9630 55.18  7820  44.72   Chi Square Value 
  n = 17450          48.24 
 
Diabetics    41 26.79   112  73.21   ‘P’ Value 
  n = 153           0.0000… 
 
The chi square value and the corresponding P value validate the statistical significance. 
 
Weight of the patient 
          n = 153 
Weight  No.  %         GDM          DM 
 Less than 50 kg 15  9.8   10  5 
 51 –  69 kg  87  56.87  72  15 
More than 70 kg 51  33.35  38  13 
            
One third of the patients weighed more than 70 kg in weight and their babies weighed 
about 3.5 to 4 kg. Maximum weight of the mother was 121 kg. 
 
Incidence with BMI of the patient 
      GDM         DM     Total 
 B M I   Nos. %  Nos.    %   Nos.    % 
 Normal 18.5 – 24.9 37 30.83    8 24.24   45 29.42 
 Over Weight 25.0 – 29.9 53 44.17   17 51.52   70 45.72 
 Obesity > 30  30 25    8 24.24   38 24.86 
 
Insulin resistance is the probable cause for over weight and obesity in DM. Body Mass 
Index based on the National Heart, Lung and Blood Institute in 1998 had indicated the 
values for normal and obese patients. The table above shows that nearly 70 % in GDM and 
75 % in DM are over weight. 
 
 
       
 
 
Mode of Delivery 
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Family History  
Among 153 patients, 68 patients gave history of Diabetes in the family - either the mother 
or father or both. The incidence of diabetes in the family is : 44.4 %. 
 Total DMCP  153  GDM 120   Known DM 33 
 Family h/o +ve   68     44    24 
 Percentage  44.4   36.6   72.7  
  
It is imperative to note that 72.7 % of patients with known GDM have a family history of 
DM. 
 
Booked Diabetics 
 
 Total no. of deliveries   153 
Booked at I O G       13 
Booked at Private Hospitals    140 
 
All cases that reported at I O G are booked at private hospitals and report here only when 
nearing term and the chance of having safe deliveries could not be ensured as we do not 
know how well they had followed the advises regarding Diabetes complicating pregnancy. 
Rise in blood sugar level in the III trimester often leads to perinatal mortality and 
morbidity. 
 
Mode of Delivery  
 
   No. of deliveries Diabetics  Statistical 
      n = 17450    n = 153  Significance 
   Nos.      %   Nos.       %        Chi Square Value 
L. Natural 9661      55.3    31      20.3  74.12        
               ‘P’ Value 
LSCS  7789       44.6   122      79.7  0.0000…   
  
The incidence of LSCS in DM complicated pregnancies is drastically higher (35% more) 
when compared with routine cases. And, the ‘P’ value is zero making the study and the 
contents statistically significant. 
 
 
       
 
Emergency vs Elective 
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Emergency Vs Elective Caesarian 
 
            All deliveries  DMCP  
   N = 7789 N = 122  Statistical  
   Nos. % Nos. % Significance 
Elective 773 9.9 29 23.7 Chi Square Value 
              23.78 
Emergency 7016 90.1 93 76.2 ‘P’ Value 
                        0.0000… 
 
Incidence of elective LSCS in DM complicating pregnancy is more than double as in the 
normal cases. The ‘P’ Value confirms the statistical significance. 
 
Gestational age - Term 
  
Total no. of deliveries    153 
Patients delivered beyond 38 weeks  129 84.32 % 
   GDM      Known DM  Total  % 
   Vaginal     13   6               19  14.72 % 
   LSCS     90  20             110  85.27 % 
   
Whether the patient is GDM or Known DM, the incidence of LSCS is certainly high at 85 
%. Among GDM patients it is seven times higher to vaginal and in DM patients it is more 
than three times that go for LSCS instead of vaginal births. 
 
Gestational age - Pre term  
Incidence of pre term deliveries was 15.68 % i.e., 24 out of 153 patients were delivered in 
less than 37 weeks and among them… 
  Vaginal    LSCS 
 12  50 %   12  50 % 
 GDM  Pre GDM  GDM  Pre GDM 
  9   3    8   4 
In pre term deliveries the mode of delivery was of equal distribution, be it vaginal or LSCS 
but in the known DM group the LSCS rate was marginally high – 4 out of 12 compared to 
3 out of 12. 
 
       
 
 
 
Baby Weight 
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Incidence of operative delivery depending upon the type of AGT during pregnancy 
 
     N = 122  Statistical  
       Nos.  %  Significance 
 
  GDM     98  81.6  Chi Square Value 
  N = 120          0.79 
 
  Known DM    24  72.7  ‘P’ Value 
  N = 33             0.3751045 
 
LSCS rate in both GDM and known DM is equal and the ‘P’ value denotes the same. 
 
Weight of Baby 
 
Weight  Diabetics   Total Deliveries 
    No.   %             Nos.        % 
< 2 kg   4  2.59       2012    11.53   
2.1 – 2.5 kg  23 14.94       4547    26.05 
2.6 – 3.0 kg  49 31.82       6144    35.20 
3.1 – 3.5 kg  50 32.47       3923    22.48 
3.6 – 4.0 kg  14   9.09         722      4.13 
 > 4.0 kg  14          9.09         102      0.58 
  Total            154          17450 
 
In our study, more than 18 % of delivered babies weighed more than 3.5 kgs. The 
maximum baby weight was 4.8 kg. In a random sampling of 200 babies the mean weight of 
the babies was 2.5 kg with a standard deviation of 0.5. 2 SD = 2.5 ± 1.0. The average 
weight fell between 1.5 kg → 3.5 kg. Babies weighing > 3.5 kg were considered as 
Macrosomia. 
 
Among 4 babies of less than 2 kgs, 2 were pre term and 2 were IUGR with severe PIH. 
 
 
 
 
       
Babies Presentation 
 Among 153 deliveries, Cephalic presentation were 143 and breech were 10. Only 
one twin was reported. 
 
 
Type of treatment 
 
  Insulin Treatment  129  84.31 % 
 Meal Plan     21 13.7 % 
  Oral Drugs       1   0.6 % 
              Insulin    (129)        Meal Plan    (21)        Oral (1) 
               GDM          DM      GDM                  DM            GDM        DM 
                  99            32         21          -     -  1 
 
Though two GDM patients were detected they delivered before treatment could be started. 
One was still born and the other was normal. Insulin doses were adjusted each month 
depending on blood sugar value. No pre GDM patient was on meal plan and the lone oral 
drug patient was a known DM. Of all GDM patients 99 (83 %) were on insulin and another 
21 (17 %) were on meal plan. 
 
Dose of insulin 
    < 20 U         21 – 50 U     >50 U      
         Known DM     14     9     7 
  GDM      70    24     5  
  
The above table shows the dosage given to the patient in the last few days of delivery. 
Insulin doses were calculated based on blood sugar levels. Fasting >95 and >140 in 
glycemic profile were taken for adjustment. Minimum to start with is 4 U. If fasting level 
is high long acting insulin level was increased, if before dinner, and bedtime glucose level 
increased intermediate acting insulin level is adjusted The total dose given is 2/3 in 
morning and 1/3 in the evening. 
 
 
 
 
       
 
Perinatal Morbidity 
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Perinatal Morbidity 
Common perinatal morbidity seen in DM complicating pregnancies were as follows: 
 
Morbidity          GDM Known GDM    Total  % 
 Respiratory Distress      14           5       19           12.3  
Hypo Calcemia      12           1                  13  8.5 
Congenital Malformation       
Neurology Defect       1              1                    2  1.2 
Cardiac Evaluation      20              5       25            16.27 
Hypoglycemia       42          13       55             35.71 
Hyperbilirubinimia      13               2                 15   9.7 
Polycythemia          2  -         2              1.2 
Pneumothorax          1             -         1   0.6 
Macrosomia          9            5                  14   9.1 
  
Hypoglycemia, Respiratory Distress and Hypocalcemia are the common earlier 
complications encountered in infants born to Diabetes Mellitus mothers. 
  
Among cardiac evaluation, x-ray findings revealed Cardiomegaly in 25 cases. Echo 
reported 21 small PDAs, L → R shunt with IAS, IVS intact / small ASD L → R shunt. 2 
cases were reported with small closing muscular VSD without PHT and 1 PFO L → R 
shunt. All these cardiac cases need to be evaluated again after six months for anomalies, as 
by that time most of the cardiac problems would have settled. 
 
Hyperbilirubinemia is encountered mostly in day 2. Among 15 cases 2 had severe icterus 
and had exchange transfusion. 
 
Congenital Malformation – Neurological defect was noticed in 2 cases of known DM, one 
with Spinabifida with Lumbosacral region small Meningomyelocele. There was also one 
case in the GDM group, which had Sacral Agenesis with Anorectal anomaly. 
 
Not withstanding these, Macrosomia is yet another complication that Obstetricians have to 
contend with. 14 cases of macrosomia were reported. > 3.5 kg (Standard Mean Value) 
weighing babies account for 28 cases, which is above normal. In our study some babies 
had more than one complication. 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
Perinatal Mortality 
     DMCP      ALL Deliveries 
    Total no of babies:  154    17450  
Mortality:   10     1184   
     Mortality Rate: 64.94 / 1000     67.95 / 1000 
 
Mortality rate was more or less equal among DM complicating pregnancy and normal 
deliveries.  
GDM / Pre GDM – Perinatal Mortality 
 Mortality     10 
Mortality among GDM babies  7 / 121  57.85 / 1000 
Mortality among known DM babies  3 / 33  90.9 / 1000 
 
Perinatal mortality is 91 % in known GDM cases when compared with GDM mothers 
(57.85 %). 
 
Perinatal Mortality based on treatment 
Of the 10 mortality babies 
 8 were on insulin 1 was on meal plan and 1 was on oral drug. 
Perinatal Mortality GA and mode of delivery 
    50 % - 5 / 10 babies - pre term  
    50 % - 5 / 10 babies - term. 
   Vaginal  2 / 4 Pre term  1 / 5 Term 
    LSCS 3 / 4 pre term  4 / 5 Term 
Among pre term mortality LSCS mode of delivery was slightly more than vaginal, whereas 
in the mortality rate among term babies, LSCS rate was found to be very high. 
Term IUD  2 (One macerated baby) 
Pre term IUD  2 (One fresh death) 
Term still birth 2 
Perinatal death term 1 
Perinatal death 1 
Congenital Anomaly 2 – One GDM & One Known DM 
Totally there were 4 IUDs, 2 stillbirths, 2 perinatal deaths and 2 of congenital anomaly. 
       
Antenatal Complication  
66 patients among 153 had antenatal complications. No morbidity was reported. 
Total deliveries  153 
Complications that are Pregnancy induced: 
  Hyper tension    27 17.6 % 
Hypothyroid     8   5.2 % 
Asthmatic     3  1.96 % 
Epilepsy     1  0.65 % 
Breech     10   6.5 % 
Twins       1  0.65 % 
Hydramnios    16  10.4 % 
  
PIH is one of the common complications associated with GDM. PIH was so severe it 
resulted in IUGR in 2 cases. The PIH incidence is 17.6 %.  
 
Postnatal Complication 
Among 153 deliveries only 6 patients had postnatal complications. 
   Atonic PPH – Sub total Hysterectomy 1 
   Hyperglycemia – Ketoacidosis  4 
Radiculopathy – Hyperglycemia  1  
  
Ketoacidosis with postoperative blood sugar of > 240 mg with acetone ++. But patient 
subsided within 2 days on insulin therapy. Radiculopathy case could not be controlled and 
insulin was continued even after discharge (10 days). PPH is not associated with DM. 
 
 
 
 
 
 
 
 
 
 
 
       
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
Discussion 
The study done at Institute of Obstetrics and Gynaecology attached to MMC, Chennai 
from August 2004 to July 2005 showed the incidence of Diabetes Mellitus complicating 
Pregnancy as 0.87 %, which corresponds to normal study. 
 
Study Incidence Mangala et al1, St.John’s Bangalore Hode et al 
 0.87%   0.7 %    0.15 – 12.3% 
 
Prevalence of GDM 
Author   Location  Prevalence 
Abell, Beishar2 Australia  0.7 
O. Sullivan3  Boston   2.5 
Mage4    Seattle   3.2 – 5.0 
Dooley5  Chicago  3.5 – 5.5 
Sacks6   Los Angeles  3.4 
Berkowitz7  Manhattan  4.6 
Murphy8  Alaska   5.8 
Natum9  Los Angeles  7.1 
Benjamin10  Zuni, New Mexico 14.3 
 Sessiah V11  Trivandrum  15 
  ,,  Erode   18.8 
  ,,  Chennai  15 
 
Type of Diabetes  
Distribution is compared with other studies as given below. 
 Our study         Mangala et al Sobhande et al12  Dume et al13 
   Total    153   38  185       Caucas   Indonesia 
   GDM   120   7 8 %  26  68 % 139 75.4 %      40%        91(70%) 
   DM      33   22 %  12 32 % 66 24.8 %      60%        37(30%) 
 
 
 
 
       
 
Age & DM 
Maternal age elicited among 153, less than 20 years were 8 cases, 87 (56.8 %) in 20 –29 
years and another 58 (37.9 %) belong to 30 – 40 years. 
< 20 yrs 0.7 %       0.7 % *  
(21 – 29 yrs 56.86 %   
30 – 40 yrs 37 %       3.8 
 
In our study P value of >30 yrs old patients among the total 153 was significant for both 
GDM and Known DM – 39 / 81 and 19 / 14.  (* Largest study based on screening - 
Coustan et al14) 
 
Parity In Diabetes 
Primi para’s among 153 patients were only 26.7 %. Common parity was G2 – G3. More 
than G4 with one live/ no baby was about 11.11 % due to the disease complication. The 
general incidence of G4 is only 4.41 %. 
 
Maternal Weight 
Maternal obesity is an independent and more important risk factor for large infants with 
GDM and glucose intolerance (Leronadu et al, 1996) 19. As per BMI except for 30.8 % rest 
were 69 % overweight among GDM and 76 % in Known DM. 
BMI  Our study   Sunebaeg et al15  
> 23.9  69 %  54.9 % 
Normal 30.8 %  45.1 % 
 
Family history of DM and Booked cases 
68 out of 153 patients gave history of mother or father or both with DM and were on either 
oral or insulin. Among this group 73 % came under pre GDM, proof that pre GDM has a 
higher incidence for h/o of DM in the family. No single case was left unbooked and most 
of them were booked elsewhere, referred to IOG during III trimester / near term. Only 13 
were booked at IOG. Increase in fasting blood sugar in III trimester leads to increased 
perinatal mortality and morbidity. 35.2 % (55) cases had increased fasting blood sugar 
nearing term, which resulted in perinatal mortality and mortality. Stillbirth could be due to 
increase in fasting blood sugar (both in GDM as well as pre GDM) – Jobstone & 
Colleagues 1990 – and 2 stillbirths were noticed in this study. 
       
 
Mode of Delivery 
Among 153 patients labour natural was 31 (20.3 %) and LSCS was 122 (79.7 %). LSCS 
rate among foetal population was about 44.6 %. 
 
Indication for greater incidence of LSCS were increased primary section, CPD, 
Macrosomia, elderly primi, BOH, Breech, GDM with PIH, Foetal distress and Cord 
presentation. 
Our Study   Mangala et al  Krishies et al16 Sobhande et al12  Hansen et al117 
LSCS       79.7 %           74 %    51 %     48 %     45.2 % 
L.Natural   20.3 %      26 %    31 %     52 %     54.8 % 
 
Among LSCS, incidence of emergency LSCS and elective were 76.21 % and 28.7%, 
which compared favourably with the total emergency LSCS and elective LSCS rate of 90 
% and 90.9 %. 
 
Gestational Age and Delivery 
There were 24 pre term deliveries and about 129 (84 %) term deliveries. The incidence of 
LSCS is high both in pre term and term deliveries. 
   Our Study Mangala  et al Kristiane et al16  Hansen et al17 
 Pre term 15.68 %   11 %      46 %    20.6 % 
 Incidence 24/ 153   4/ 38      78/ 166 
 
Weight of baby 
Babies of > 4kg were 14 and those more than 3.5 were 14, while it was 18 % in diabetes it 
was only 4.7 % of all total deliveries. 
 
Macrosomic infants of diabetic mothers are described anthropometrically different from 
other large gestational age infants (McFarland & associates 2000, Modanlou20 & 
colleagues 1982). 
   
Our study Mangala et al Tea cs et al18 Kitzmiller et al 
Weight      9.09 % 36.8 %  3.8 %  11 % 
> 4 kg   (no – 38) (no – 216) 
 
       
 
Presentation 
Cephalic presentation was noticed in 143 patients and 10 with breech. There was also a 
twin, with both babies hypoglycemic, treated with 10 % dextrose. 
 
56 (36.36 %) normal babies were without any abnormalities as they were under good 
glycemic control. These babies were also kept in pre term for 48 hours, advised for 
warmth, breast feed, inj. Vit.K 1 amp IM and glucose level monitored at 4, 6, 24 and 48 
hours. 
 
Management 
More than 85 % were on insulin and 21 were on meal plan and one continued oral drug. 
All known DM, except one was on insulin. Among GDM, 99 were on insulin and 21 on 
meal plan. Perinatal mortality and morbidity increased among patients on meal plan and 
patients who had insulin only for 4 days prior to delivery. The lone patient on oral drug 
also resulted in perinatal mortality. Fasting glucose > 110 mg will not respond to 
Glyburide therapy (Conway et al21, 2004)    
Our study  Teacs et al18 
Insulin     131/ 153 85 % 210 40 % 
Meal Plan      21/ 153   80 % 
 
Perinatal Morbidity 
Respiratory Distress Syndrome (RDS), Hypoglycemia, Hyperbilirubinemia, Hypocalcemia 
were the common problems faced in this study.  
 
Insulin is generally administered in two to three times depending on blood sugar value. 
Combination of intermediate acting and regular insulin is given before breakfast and dinner 
(2:1 ratio). Patient was given 2/3 of their total dose with breakfast and remaining 1/3 in the 
evening as a combined dose with dinner or split in to components with regular insulin at 
dinnertime and with intermediate acting insulin at bedtime.  (0.7 U/kg I trimester, 0.8 U/kg 
at II trimester and 1 U/kg at III trimester). 
 
Hypoglycemia was reported in 55 cases and they all had increased blood sugar in the III 
trimester. Patients with glucose level of < 35 mg, within 1 hour, were given 10 % Dextrose 
6 cc, iv bolous followed by 10 % Dextrose 180 ml, 200 ml for 0 – 24 hours, depend on 
       
blood sugar level continued even for 3 days. Rapid decrease in plasma glucose level after 
delivery is characteristic of infants of diabetic mothers. It is attributed to hyperplasia of the 
foetal β islet cells induced by chronic maternal hyperglycemia. Taylor (2002) found 
neonatal hypoglycemia < 45 mg before second feeding was related to maternal blood sugar 
exceeding 145 mg / day during labour. Prompt recognition and treatment of hypoglycemic 
infant helped in minimising sequlae. 
 
The incidence of Hyperbilirubinemia was 9 % compared to Mangala et al study that 
reported 19 %. One patient had exchange transfusion due to increased bilirubin level 
within 24 hrs. Phototherapy was given for 4 days. Other cases of hyperbilirubin were also 
treated with phototherapy. 
 
Patients’ outcome associated with good diabetic control 
 Study         Our Values       Game et al        Kitzmiller et al  Levenot et al 
 Patients   153  260  134  120 
 Fasting B.S  95 – 120 109 – 140 105 – 121 145 – 153 
 PNM / 1000  64.94 % 46 %  37 %  42 % 
 Macrosomia  9 %  22 %  11 %  12 % 
 Hypoglycemia  35 %  39 %  49 %  28 % 
  
Patients who had jitteriness were examined carefully and their calcium levels were found 
to be < 7 mg and the treatment was 5 to 7.5 ml /kg, IV infusion of calcium gluconate for 24 
hours and 2 ml / kg x 3 days. Oral calcium 60 ml / kg was administered till the calcium 
level rose to normal. Each 5ml contains 125 elemental calcium. Morbidity complications 
are of increased distribution among the known diabetic compared to GDM patients. 
  
All babies of DMCP were admitted in pre term ward and evaluated for cardiology problem 
using x-ray chest, ECG and Echo. Cardiomegalies, PDA, ASD with L → R shunt were 
reported in 25 cases. But most of cardiology problems will settle down by six months 
(Way, 1979). As per echo, Cardiomegaly is reported in 25. Small PDA with L → R shunt 
and small ASD with L → R shunt in 21 cases. These problems may get resolved in six 
months, if persisting they may surface after this period as malformations (Way et al, J. 
Paed. 95: 1020, 1979). Pederson et al 853 IDM babies found 1.7 % cardiac malformations. 
Roward et al 470 DM 4 % cardiac malformation (50 % mainly VSD) Driscol & Pederson 
proved VSD as the single most anomaly. 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
Perinatal Mortality 
The perinatal mortality was 10 among 154 babies and the PNM Rate of DMCP was 64.94 
/1000. The Normal PNMR was 1184 / 17450 – 67.85 /1000. Due to pre conception 
counselling and good glycemic control the PNM Rate is lower in DMCP.Mortality has 
been 90.9 % in Known DM and 57.8 % in GDM. This shows that glycemic control is well 
maintained in GDM compared to known DM. 
  Our Study  Sobhande et al 12 Mizal et al 
  10/ 153  10/ 185 
  6.4 %   5.7 %   10.5 % 
 
Congenital Malformations among 154 babies were 2 with confirmed malformations (1.2 
%) – one with Spinabifida, Myelomeningocele feature suggestive of Arnold Chiari 
syndrome and the other with Sacral agenesis and anorectal anomaly. 
  
Adashi and Co-worker study 18 month reported 113 Diabetic pregnancy - 81 GDM (diet 
controlled), 6 (insulin) and 26 pre gestational insulin dependant diabetic insulin. Rate of 
congenital malformation: 5.3 % diet controlled GDM. NO malformation in offsprings of 
women with either GDM / known DM receiving insulin. According to White DM related 
malformation was 3 – 4 %. Caudal regression syndrome was pathognomonic of diabetic 
induced malformation. 
 
One on oral drugs and one on meal plan resulted in mortality. Five were pre term and five 
were term. Incidence of mortality in pre term is comparatively higher than that of term 
babies. 
 
Among two term IUDs, one was macerated whose mother was on meal plan with irregular 
check up. Patient reported at IOG with loss of foetal movement delivered labour naturally. 
The other term IUD was on human insulin only for the last 10 days. LSCS was resorted to 
as the fasting blood sugar was higher. 
 
Among two pre term IUDs one was on oral drug, pre GDM and on insulin. Previous baby 
for this patient had myelomeningocele and died. Other pre term IUD was with previous 
LSCS glycemic control was not good. 
 
       
Of the two stillbirths, one was GDM and other Pre GDM. Both babies were about 4 kg. 
Pregnancies in women with overt diabetes are at greater risk for foetal death. The danger is 
not apparent for those who have only postprandial hyperglycemia (Lucas & Co worker, 
1993, Sheffield, 2002). 
 
One GDM with congenital anomaly spina bifida, myelomeningocele at lumbar region was 
on insulin since fifth month. She was terminated with bougie application at seventh month, 
delivered normally and other with sacral agenesis with anorectal anomaly was on insulin 
before conception, delivered by LSCS. 
 
O’Sullivan observed fourfold increase in PNMR in prognosing improperly managed GDM. 
Several other studies have found an increased rate of still births in untreated GDM. Today 
in pregnancies identified and treated appropriately, intra uterine foetal is not increased. 
 
Antenatal 
66 among 153 patients had associated complications – 43.1 %. Common complications 
were breech, Hydramnios, Hypertension, Hypo thyroid. Rare were asthmatic, epilepsy and 
twins. 
  Our study Mangala et al Hansen et al17 
 PIH 17.6 %  31.5 %  20.6 % 
  N = 153 38  491   
 
Hypertension (17.6 %) induced or exacerbated by pregnancy is the major complication that 
most often forces delivery in diabetic women. Special risk factors for Pre eclampsia 
include any vascular complication and pre existing proteineuria with or without chronic 
hypertension. Sibbai & colleagues, 2000 reported 11 % class B, 22 % Class C, 21 in class 
D and 36 in class FR. Interestingly the incidence of Pre eclampsia does not seem to be 
related to glucose control (Garner & Co authors, 1990). 
 
Ketoacidosis reported only in four cases (1.3 %). Common incidence of ketoacidosis is 
about 1 % of Diabetic pregnancies. It remains one of most serious complications (Garner, 
1995). One patient went in atonic PPH and ended in sub total hysterectomy. This patient 
was on meal plan. Fasting blood sugar on the day of surgery was 110 mg. 
       
More recent reports indicated that improved glycemic control is associated with significant 
reduction in various obstetric complications. DKA 0.7 %( Kilvert et a)l, Hydramnios 2 % 
and pre term labour 8.1 %. 
 
One patient of known DM had weakness of lower limb (Radiculopathy). Postoperative 
blood sugar was increased and it was controlled with insulin drip was maintained for 10 
days according to blood sugar level and advised to continue treatment consulting 
diabetologist. 
 
  
  
 
 
  
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
       
 
 
 
 
 
SUMMARY 
 
 
 
 
 
 
 
 
 
 
       
Summary 
Incidence of diabetes:      0.87 % 
Percentage of GDM: 78.4 %. Known DM:   21.56 % 
Distribution among G2 & G3:     62.09 % 
  ≥ G4:      11.11 %  
Over weight and obesity distribution is: GDM:  69.1 %  
                 Known DM:  75.7 % 
Term delivery:       84.3 %  
Pre term delivery:      15.68 % 
Family History +ve GDM:     36.6 % 
  Known DM:     72.7 % 
Mode of Delivery L.Natural:     20.3 % 
      LSCS:     79.7% 
Among LSCS emergency LSCS:    76.2 % 
Macrosomia :       9.09 % 
Mode of Treatment- Insulin:     84.3 %  
Meal Plan:      13.7 % 
Oral drug:      0.6 % 
Morbidities in DM babies were 
Respiratory Distress Syndrome:    12 %,  
Hypoglycemia       35.9 % 
  Hypocalcemia       18 % 
Hyperbilirubinemia       9.7 % 
Congenital Malformation – Neurological Defect:   1.2 % 
Cardiac Evaluation:      16.27 % 
Perinatal Mortality:       10 / 154   
GDM :        57.85/ 1000,  
KDM :        90.9/ 1000 
PNMR – Diabetes Mellitus complicating Pregnancy:  64.94 / 1000  
Normal:  67.95 / 1000 
 
 
 
       
Among 10 babies, 2 were term IUD, 2 pre term IUD, 2 still births,  
2 Perinatal deaths (term & pre term) and 2 congenital malformation deaths. 
Maternal associated complications were:  PIH  17.6 % 
  Hypothyroid:   5.2 %  
Hydramnios: 10.4 %) 
Associated postnatal complication was only in 6 cases.  
4 with Ketoacidosis corrected,  
1 with Radiculopathy - continued treatment,  
1 ended in PPH →Subtotal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
 
 
 
 
CONCLUSION 
 
 
 
 
 
 
 
 
 
 
       
Conclusion 
 
 
Despite the changing trends in obstetrics, it is mandatory to have an uptodate knowledge, 
diagnosis, appropriate decision and management in labour. A careful intervention will 
avoid long-term complications; help reduce perinatal mortality and late sequalae.  
 
The Perinatal Mortality Rate of Diabetes Mellitus Complicating Pregnancy is more or less 
equal to normal babies. Perinatal outcome, which is little higher in DM preceding 
pregnancy, can be overcome by pre conceptional counselling and good glycemic control.      
 
Pre conceptional glycemic control and control around the critical period of organogenesis 
(7th – 8th week) though done at present needs to be carried out vigorously and effectively so 
as to help in lowering the incidence of congenital malformation. 
 
The incidence of caesarian section can be reduced in Diabetes Mellitus complicating 
pregnancy to an extent by carefully monitoring the glycemic control, which in turn will 
lower the macrosomia rate, and by minimizing primary section. 
 
Thus with the use of frequent home glucose monitoring, diet, insulin and team approach it 
is possible to achieve euglycemia in most diabetic pregnancies and prevent much of the 
perinatal mortality and morbidity. 
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Proforma 
Name:    Age:  Ht:  Wt: 
Socio Economic Status:     IP No.: 
Address 
Rural / Urban    Income Level: 
Reference:    Booked: Yes / No 
Gravida:  Para:   Abortions: 
Antenatal Check up: Regular / Irregular 
Malpresentation: 
I. Obstetrical History 
Previous GDM: Yes / No When Diagnosed: I / II/ III Trimester 
Mode of Treatment: 
History of other complication: 
Mode of delivery: Vaginal / LSCS Indication: 
Baby: Term/ Pre term/ IUGR / Big Baby Weight of baby: 
Complication of baby:   When stopped treatment: 
II. Known DM 
Age at diagnosis of Diabetes Mellitus 
Type of DM: Type I / II/ Other Mode of Treatment: 
Complication of DM before conception: 
Complication of DM after conception: 
Associated Complication: 
III. GDM Time of diagnosis: I Trimester / II / III 
 Complication associated: PIH / Hypothyroid/ Asthma/ Hydramnios 
 Mode of Treatment: Insulin/ Meal Plan/ Oral 
 Type & dose of insulin: 
Mother: Duration of stay in hospital 
    Mode of delivery:  Indication of induction 
Baby:  Weight:  Length: APGAR  HC: 
  Anomalies:  AC: 
  Morbidities: Hypocalcemia/ Hyperbilirubinemia/ Hypoglycemia 
    Respiratory Disorder/ Cardiac Evaluation 
Placenta: 
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Abbreviations used 
 
RDS  Respiratory Distress Syndrome 
GDM  Gestational Diabetes Mellitus 
IDDM  Insulin Dependent Diabetes Mellitus 
NDDM Non insulin Dependent Diabetes Mellitus 
GCI  Glucose Corbohydrate Intolerance 
DM  Daibetes Mellitus 
KDM  Known Diabetes Mellitus 
GTT  Glucose Tolerance Test 
IGT  Impaired Glucose Tolerance Test 
ADA  American Diabetics Association 
ACOG  American College of Gynecologists and Obstetricians 
ICU  Intensive Care Unit 
NST  Non Stress Test 
PPH  Post Partum Haemorrhage  
ECG  Electro Cardio Graph 
PDA  Patent Ductus Arteriosis 
ASD  Atrial Septal Defect 
VSD  Ventricular Septal Defect 
HC  Head Circumferance 
AC  Abdominal Circumference 
IUD  Intra Uterine Death 
DKA  Diabetic Keto Acidosis 
USG  Ultra Sono Gram 
PIH  Pregnancy Induced Hypertension 
T  Term 
PT  Pre Term 
Hyd  Hydramnios 
Hth  Hypo Thyroid 
HT  Hyper Tension 
HyB  Hyper Bilirubinemia 
Br  Breech 
C  Hyper Calcemia 
G  Hyper Glycemia 
 
  
  
